Endurant Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-6,258
| Closed | -$1.36M | – | 57 |
|
|
2022
Q4 | $1.36M | Buy |
+6,258
| New | +$1.36M | 0.55% | 33 |
|
|
2022
Q2 | – | Sell |
-3,308
| Closed | -$939K | – | 55 |
|
|
2022
Q1 | $939K | Sell |
3,308
-15,278
| -82% | -$4.34M | 0.25% | 55 |
|
|
2021
Q4 | $7M | Buy |
+18,586
| New | +$7M | 1.69% | 17 |
|
|
2020
Q2 | – | Sell |
-13,147
| Closed | -$1.66M | – | 61 |
|
|
2020
Q1 | $1.66M | Buy |
+13,147
| New | +$1.66M | 0.75% | 31 |
|
|
2019
Q4 | – | Sell |
-74,986
| Closed | -$9.93M | – | 56 |
|
|
2019
Q3 | $9.93M | Buy |
+74,986
| New | +$9.93M | 3.56% | 11 |
|
|
2017
Q3 | – | Sell |
-28,248
| Closed | -$2.86M | – | 89 |
|
|
2017
Q2 | $2.86M | Buy |
28,248
+4,460
| +19% | +$451K | 0.81% | 36 |
|
|
2017
Q1 | $2.14M | Buy |
23,788
+5,300
| +29% | +$477K | 0.69% | 42 |
|
|
2016
Q4 | $1.41M | Sell |
18,488
-17,300
| -48% | -$1.32M | 0.58% | 46 |
|
|
2016
Q3 | $2.98M | Sell |
35,788
-4,300
| -11% | -$358K | 1.11% | 32 |
|
|
2016
Q2 | $3.31M | Buy |
40,088
+29,200
| +268% | +$2.41M | 1.1% | 29 |
|
|
2016
Q1 | $827K | Buy |
10,888
+2,300
| +27% | +$175K | 0.27% | 60 |
|
|
2015
Q4 | $690K | Buy |
8,588
+2,088
| +32% | +$168K | 0.23% | 62 |
|
|
2015
Q3 | $413K | Buy |
+6,500
| New | +$413K | 0.14% | 68 |
|